- Report
- October 2025
- 26 Pages
South Africa
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 22 Pages
North Macedonia
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 25 Pages
France
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 25 Pages
Saudi Arabia
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 21 Pages
Indonesia
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 23 Pages
France
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 25 Pages
China, Hong Kong
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 21 Pages
Saudi Arabia
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 22 Pages
Indonesia
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 25 Pages
Thailand
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 26 Pages
China, Hong Kong
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 22 Pages
Uzbekistan
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 21 Pages
Uzbekistan
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 24 Pages
Greece
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 23 Pages
Portugal
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 22 Pages
Greece
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 20 Pages
Portugal
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 24 Pages
Greece
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 22 Pages
Portugal
From €995EUR$1,181USD£890GBP
- Report
- October 2025
- 22 Pages
Denmark
From €995EUR$1,181USD£890GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more